Esperion Therapeutics Inc. (ESPR) Declined -6.84% or -3.3 To Price $44.95 On Friday


Esperion Therapeutics Inc. (ESPR) declined -6.84% or -3.3 to $44.95. It is nearly 587989 shares traded, which is 109.79% compare to the average total volume 535565. The market cap of ESPR is $1.20 billion. The year to date change is -34.28%. The 52 week price range is from $33.06 to $82.68. Price of ESPR have changed 4.39% during last week. It have changed 2.09% over last month, 10.26% over last 3 months, -35.63% over last 6 months and 0.35% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for ESPR is 47.19. It is 4.98% above current price. The 200-day Moving Averages for ESPR is 55.72. It is 23.96% above current price. The 52-week High is 82.68. It is 83.94% from the current price. The 52-week Low is 33.06. It is -26.45% from current price.

Some people may be interesting about short interest ratio of a stock. The short interest ratio of ESPR is 11.26 on 2018-09-28. Short % to float is 21.94%. There are some statistics of ESPR. It is has market cap $1.20 billion. The share outstanding is 26.80 million. The average volume is 535565. It has 403.57M cash and 2.52M in debt. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of ESPR is -104.92%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of ESPR is -87.41%.


Tags:

Share this post